Paige, Perspectum forge AI-centered clinical trial alliance

By Emily Jarecki

- Last updated on GMT

(PM Images/iStock via Getty Images Plus)
(PM Images/iStock via Getty Images Plus)

Related tags Artificial intelligence Data management Liver Liver disease Pathology

The digital pathology firm and image-analysis software developer will partner on artificial intelligence based solutions to improve trial decision making.

Perspectum, a software developer focused on image analysis solutions, and digital pathology company Paige have announced a partnership. According to the two firms, their teams plan to work together to use artificial intelligence (AI) and quantitative tools to help enhance decision-making abilities in trials, and to empower pathologists.

“We are excited to partner with Paige and to work together to find better ways to improve the delivery of services and the quality of histology biomarkers in late-phase trials,”​ said Rajarshi Banerjee, CEO of Perspectum. “Paige’s mission to develop the next generation of computational technology that can translate into effective, personalized care for patients is a shared mission, and ​[Paige CEO] Leo Grady has built a wonderful team to address the digital transformation of pathology.”

This partnership will combine Perspectum’s digital pathology service and integrated repository platform for both non-invasive and histology datasets with Paige’s digital pathology software tools which include FullFocus, an FDA-cleared and CE-marked digital pathology viewing platform. This will enhance clinical trials by streamlining the operational workflow and allowing access to novel decision support tools for pathologists.

Ultimately these improvements will increase the robustness and reliability of trials and allow pharmaceutical sponsors to overcome the pitfalls and obstacles traditionally associated with pathology endpoints in clinical trials,” ​said Vidhya Kumar, vice president of business development for pharma solutions with Perspectum.

Focus on liver disease

Kumar said, “Liver disease is a major concern in the US, and Perspectum has developed non-invasive, imaging-based biomarkers as well as digital pathology tools to better characterize and understand these conditions. This partnership combines Perspectum’s experience in the management and delivery of biomarkers for liver disease clinical trials with Paige’s broader expertise in pathology.”

“Paige looks forward to contributing its expertise in computational pathology and collaborating with Perspectum to modernize pathology workflows in the clinical trial setting with the ultimate aim of improving the diagnosis and treatment of liver disease,”​ said Grady.

Related news

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us